Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: QYResearch | PRODUCT CODE: 1273090

Cover Image

PUBLISHER: QYResearch | PRODUCT CODE: 1273090

Global Computational Drug Discovery Market Insights, Forecast to 2029

PUBLISHED:
PAGES: 110 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4900
PDF (Multi User License)
USD 7350
PDF (Enterprise User License)
USD 9800

Add to Cart

This research report focuses on the Computational Drug Discovery Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Computational Drug Discovery Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Structure-based Drug Design (SBDD)
    • 1.2.3 Ligand-based Drug Design (LBDD)
    • 1.2.4 Sequence-based Approaches
  • 1.3 Market by Application
    • 1.3.1 Global Computational Drug Discovery Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Oncological Disorders
    • 1.3.3 Neurological Disorders
    • 1.3.4 Immunological Disorders
    • 1.3.5 Infectious Diseases
    • 1.3.6 Others
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Computational Drug Discovery Market Perspective (2018-2029)
  • 2.2 Global Computational Drug Discovery Growth Trends by Region
    • 2.2.1 Computational Drug Discovery Market Size by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Computational Drug Discovery Historic Market Size by Region (2018-2023)
    • 2.2.3 Computational Drug Discovery Forecasted Market Size by Region (2024-2029)
  • 2.3 Computational Drug Discovery Market Dynamics
    • 2.3.1 Computational Drug Discovery Industry Trends
    • 2.3.2 Computational Drug Discovery Market Drivers
    • 2.3.3 Computational Drug Discovery Market Challenges
    • 2.3.4 Computational Drug Discovery Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Computational Drug Discovery by Players
    • 3.1.1 Global Computational Drug Discovery Revenue by Players (2018-2023)
    • 3.1.2 Global Computational Drug Discovery Revenue Market Share by Players (2018-2023)
  • 3.2 Global Computational Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Computational Drug Discovery, Ranking by Revenue, 2021 VS 2022 VS 2023
  • 3.4 Global Computational Drug Discovery Market Concentration Ratio
    • 3.4.1 Global Computational Drug Discovery Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Computational Drug Discovery Revenue in 2022
  • 3.5 Global Key Players of Computational Drug Discovery Head office and Area Served
  • 3.6 Global Key Players of Computational Drug Discovery, Product and Application
  • 3.7 Global Key Players of Computational Drug Discovery, Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Computational Drug Discovery Breakdown Data by Type

  • 4.1 Global Computational Drug Discovery Historic Market Size by Type (2018-2023)
  • 4.2 Global Computational Drug Discovery Forecasted Market Size by Type (2024-2029)

5 Computational Drug Discovery Breakdown Data by Application

  • 5.1 Global Computational Drug Discovery Historic Market Size by Application (2018-2023)
  • 5.2 Global Computational Drug Discovery Forecasted Market Size by Application (2024-2029)

6 North America

  • 6.1 North America Computational Drug Discovery Market Size (2018-2029)
  • 6.2 North America Computational Drug Discovery Market Size by Type
    • 6.2.1 North America Computational Drug Discovery Market Size by Type (2018-2023)
    • 6.2.2 North America Computational Drug Discovery Market Size by Type (2024-2029)
    • 6.2.3 North America Computational Drug Discovery Market Share by Type (2018-2029)
  • 6.3 North America Computational Drug Discovery Market Size by Application
    • 6.3.1 North America Computational Drug Discovery Market Size by Application (2018-2023)
    • 6.3.2 North America Computational Drug Discovery Market Size by Application (2024-2029)
    • 6.3.3 North America Computational Drug Discovery Market Share by Application (2018-2029)
  • 6.4 North America Computational Drug Discovery Market Size by Country
    • 6.4.1 North America Computational Drug Discovery Market Size by Country: 2018 VS 2022 VS 2029
    • 6.4.2 North America Computational Drug Discovery Market Size by Country (2018-2023)
    • 6.4.3 North America Computational Drug Discovery Market Size by Country (2024-2029)
    • 6.4.4 United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Computational Drug Discovery Market Size (2018-2029)
  • 7.2 Europe Computational Drug Discovery Market Size by Type
    • 7.2.1 Europe Computational Drug Discovery Market Size by Type (2018-2023)
    • 7.2.2 Europe Computational Drug Discovery Market Size by Type (2024-2029)
    • 7.2.3 Europe Computational Drug Discovery Market Share by Type (2018-2029)
  • 7.3 Europe Computational Drug Discovery Market Size by Application
    • 7.3.1 Europe Computational Drug Discovery Market Size by Application (2018-2023)
    • 7.3.2 Europe Computational Drug Discovery Market Size by Application (2024-2029)
    • 7.3.3 Europe Computational Drug Discovery Market Share by Application (2018-2029)
  • 7.4 Europe Computational Drug Discovery Market Size by Country
    • 7.4.1 Europe Computational Drug Discovery Market Size by Country: 2018 VS 2022 VS 2029
    • 7.4.2 Europe Computational Drug Discovery Market Size by Country (2018-2023)
    • 7.4.3 Europe Computational Drug Discovery Market Size by Country (2024-2029)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 China

  • 8.1 China Computational Drug Discovery Market Size (2018-2029)
  • 8.2 China Computational Drug Discovery Market Size by Type
    • 8.2.1 China Computational Drug Discovery Market Size by Type (2018-2023)
    • 8.2.2 China Computational Drug Discovery Market Size by Type (2024-2029)
    • 8.2.3 China Computational Drug Discovery Market Share by Type (2018-2029)
  • 8.3 China Computational Drug Discovery Market Size by Application
    • 8.3.1 China Computational Drug Discovery Market Size by Application (2018-2023)
    • 8.3.2 China Computational Drug Discovery Market Size by Application (2024-2029)
    • 8.3.3 China Computational Drug Discovery Market Share by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Computational Drug Discovery Market Size (2018-2029)
  • 9.2 Asia Computational Drug Discovery Market Size by Type
    • 9.2.1 Asia Computational Drug Discovery Market Size by Type (2018-2023)
    • 9.2.2 Asia Computational Drug Discovery Market Size by Type (2024-2029)
    • 9.2.3 Asia Computational Drug Discovery Market Share by Type (2018-2029)
  • 9.3 Asia Computational Drug Discovery Market Size by Application
    • 9.3.1 Asia Computational Drug Discovery Market Size by Application (2018-2023)
    • 9.3.2 Asia Computational Drug Discovery Market Size by Application (2024-2029)
    • 9.3.3 Asia Computational Drug Discovery Market Share by Application (2018-2029)
  • 9.4 Asia Computational Drug Discovery Market Size by Region
    • 9.4.1 Asia Computational Drug Discovery Market Size by Region: 2018 VS 2022 VS 2029
    • 9.4.2 Asia Computational Drug Discovery Market Size by Region (2018-2023)
    • 9.4.3 Asia Computational Drug Discovery Market Size by Region (2024-2029)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 China Taiwan
    • 9.4.7 Southeast Asia
    • 9.4.8 India
    • 9.4.9 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Computational Drug Discovery Market Size (2018-2029)
  • 10.2 Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Type (2018-2023)
    • 10.2.2 Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Type (2024-2029)
    • 10.2.3 Middle East, Africa, and Latin America Computational Drug Discovery Market Share by Type (2018-2029)
  • 10.3 Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Application (2018-2023)
    • 10.3.2 Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Application (2024-2029)
    • 10.3.3 Middle East, Africa, and Latin America Computational Drug Discovery Market Share by Application (2018-2029)
  • 10.4 Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Country: 2018 VS 2022 VS 2029
    • 10.4.2 Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Country (2018-2023)
    • 10.4.3 Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Country (2024-2029)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Saudi Arabia
    • 10.4.8 Israel
    • 10.4.9 GCC Countries

11 Key Players Profiles

  • 11.1 AMRI
    • 11.1.1 AMRI Company Details
    • 11.1.2 AMRI Business Overview
    • 11.1.3 AMRI Computational Drug Discovery Introduction
    • 11.1.4 AMRI Revenue in Computational Drug Discovery Business (2018-2023)
    • 11.1.5 AMRI Recent Developments
  • 11.2 Charles River
    • 11.2.1 Charles River Company Details
    • 11.2.2 Charles River Business Overview
    • 11.2.3 Charles River Computational Drug Discovery Introduction
    • 11.2.4 Charles River Revenue in Computational Drug Discovery Business (2018-2023)
    • 11.2.5 Charles River Recent Developments
  • 11.3 Schrodinger
    • 11.3.1 Schrodinger Company Details
    • 11.3.2 Schrodinger Business Overview
    • 11.3.3 Schrodinger Computational Drug Discovery Introduction
    • 11.3.4 Schrodinger Revenue in Computational Drug Discovery Business (2018-2023)
    • 11.3.5 Schrodinger Recent Developments
  • 11.4 Evotec
    • 11.4.1 Evotec Company Details
    • 11.4.2 Evotec Business Overview
    • 11.4.3 Evotec Computational Drug Discovery Introduction
    • 11.4.4 Evotec Revenue in Computational Drug Discovery Business (2018-2023)
    • 11.4.5 Evotec Recent Developments
  • 11.5 Bayers
    • 11.5.1 Bayers Company Details
    • 11.5.2 Bayers Business Overview
    • 11.5.3 Bayers Computational Drug Discovery Introduction
    • 11.5.4 Bayers Revenue in Computational Drug Discovery Business (2018-2023)
    • 11.5.5 Bayers Recent Developments
  • 11.6 GVK Biosciences
    • 11.6.1 GVK Biosciences Company Details
    • 11.6.2 GVK Biosciences Business Overview
    • 11.6.3 GVK Biosciences Computational Drug Discovery Introduction
    • 11.6.4 GVK Biosciences Revenue in Computational Drug Discovery Business (2018-2023)
    • 11.6.5 GVK Biosciences Recent Developments
  • 11.7 AstraZeneca
    • 11.7.1 AstraZeneca Company Details
    • 11.7.2 AstraZeneca Business Overview
    • 11.7.3 AstraZeneca Computational Drug Discovery Introduction
    • 11.7.4 AstraZeneca Revenue in Computational Drug Discovery Business (2018-2023)
    • 11.7.5 AstraZeneca Recent Developments
  • 11.8 BioDuro
    • 11.8.1 BioDuro Company Details
    • 11.8.2 BioDuro Business Overview
    • 11.8.3 BioDuro Computational Drug Discovery Introduction
    • 11.8.4 BioDuro Revenue in Computational Drug Discovery Business (2018-2023)
    • 11.8.5 BioDuro Recent Developments
  • 11.9 BOC Sciences
    • 11.9.1 BOC Sciences Company Details
    • 11.9.2 BOC Sciences Business Overview
    • 11.9.3 BOC Sciences Computational Drug Discovery Introduction
    • 11.9.4 BOC Sciences Revenue in Computational Drug Discovery Business (2018-2023)
    • 11.9.5 BOC Sciences Recent Developments
  • 11.10 Aris Pharmaceuticals
    • 11.10.1 Aris Pharmaceuticals Company Details
    • 11.10.2 Aris Pharmaceuticals Business Overview
    • 11.10.3 Aris Pharmaceuticals Computational Drug Discovery Introduction
    • 11.10.4 Aris Pharmaceuticals Revenue in Computational Drug Discovery Business (2018-2023)
    • 11.10.5 Aris Pharmaceuticals Recent Developments
  • 11.11 ChemDiv
    • 11.11.1 ChemDiv Company Details
    • 11.11.2 ChemDiv Business Overview
    • 11.11.3 ChemDiv Computational Drug Discovery Introduction
    • 11.11.4 ChemDiv Revenue in Computational Drug Discovery Business (2018-2023)
    • 11.11.5 ChemDiv Recent Developments
  • 11.12 RTI International
    • 11.12.1 RTI International Company Details
    • 11.12.2 RTI International Business Overview
    • 11.12.3 RTI International Computational Drug Discovery Introduction
    • 11.12.4 RTI International Revenue in Computational Drug Discovery Business (2018-2023)
    • 11.12.5 RTI International Recent Developments
  • 11.13 XRQTC
    • 11.13.1 XRQTC Company Details
    • 11.13.2 XRQTC Business Overview
    • 11.13.3 XRQTC Computational Drug Discovery Introduction
    • 11.13.4 XRQTC Revenue in Computational Drug Discovery Business (2018-2023)
    • 11.13.5 XRQTC Recent Developments
  • 11.14 Pharmaron
    • 11.14.1 Pharmaron Company Details
    • 11.14.2 Pharmaron Business Overview
    • 11.14.3 Pharmaron Computational Drug Discovery Introduction
    • 11.14.4 Pharmaron Revenue in Computational Drug Discovery Business (2018-2023)
    • 11.14.5 Pharmaron Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Computational Drug Discovery Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Structure-based Drug Design (SBDD)
    • 1.2.3 Ligand-based Drug Design (LBDD)
    • 1.2.4 Sequence-based Approaches
  • 1.3 Market by Application
    • 1.3.1 Global Computational Drug Discovery Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Oncological Disorders
    • 1.3.3 Neurological Disorders
    • 1.3.4 Immunological Disorders
    • 1.3.5 Infectious Diseases
    • 1.3.6 Others
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Computational Drug Discovery Market Perspective (2018-2029)
  • 2.2 Global Computational Drug Discovery Growth Trends by Region
    • 2.2.1 Computational Drug Discovery Market Size by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Computational Drug Discovery Historic Market Size by Region (2018-2023)
    • 2.2.3 Computational Drug Discovery Forecasted Market Size by Region (2024-2029)
  • 2.3 Computational Drug Discovery Market Dynamics
    • 2.3.1 Computational Drug Discovery Industry Trends
    • 2.3.2 Computational Drug Discovery Market Drivers
    • 2.3.3 Computational Drug Discovery Market Challenges
    • 2.3.4 Computational Drug Discovery Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Computational Drug Discovery by Players
    • 3.1.1 Global Computational Drug Discovery Revenue by Players (2018-2023)
    • 3.1.2 Global Computational Drug Discovery Revenue Market Share by Players (2018-2023)
  • 3.2 Global Computational Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Computational Drug Discovery, Ranking by Revenue, 2021 VS 2022 VS 2023
  • 3.4 Global Computational Drug Discovery Market Concentration Ratio
    • 3.4.1 Global Computational Drug Discovery Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Computational Drug Discovery Revenue in 2022
  • 3.5 Global Key Players of Computational Drug Discovery Head office and Area Served
  • 3.6 Global Key Players of Computational Drug Discovery, Product and Application
  • 3.7 Global Key Players of Computational Drug Discovery, Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Computational Drug Discovery Breakdown Data by Type

  • 4.1 Global Computational Drug Discovery Historic Market Size by Type (2018-2023)
  • 4.2 Global Computational Drug Discovery Forecasted Market Size by Type (2024-2029)

5 Computational Drug Discovery Breakdown Data by Application

  • 5.1 Global Computational Drug Discovery Historic Market Size by Application (2018-2023)
  • 5.2 Global Computational Drug Discovery Forecasted Market Size by Application (2024-2029)

6 North America

  • 6.1 North America Computational Drug Discovery Market Size (2018-2029)
  • 6.2 North America Computational Drug Discovery Market Size by Type
    • 6.2.1 North America Computational Drug Discovery Market Size by Type (2018-2023)
    • 6.2.2 North America Computational Drug Discovery Market Size by Type (2024-2029)
    • 6.2.3 North America Computational Drug Discovery Market Share by Type (2018-2029)
  • 6.3 North America Computational Drug Discovery Market Size by Application
    • 6.3.1 North America Computational Drug Discovery Market Size by Application (2018-2023)
    • 6.3.2 North America Computational Drug Discovery Market Size by Application (2024-2029)
    • 6.3.3 North America Computational Drug Discovery Market Share by Application (2018-2029)
  • 6.4 North America Computational Drug Discovery Market Size by Country
    • 6.4.1 North America Computational Drug Discovery Market Size by Country: 2018 VS 2022 VS 2029
    • 6.4.2 North America Computational Drug Discovery Market Size by Country (2018-2023)
    • 6.4.3 North America Computational Drug Discovery Market Size by Country (2024-2029)
    • 6.4.4 United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Computational Drug Discovery Market Size (2018-2029)
  • 7.2 Europe Computational Drug Discovery Market Size by Type
    • 7.2.1 Europe Computational Drug Discovery Market Size by Type (2018-2023)
    • 7.2.2 Europe Computational Drug Discovery Market Size by Type (2024-2029)
    • 7.2.3 Europe Computational Drug Discovery Market Share by Type (2018-2029)
  • 7.3 Europe Computational Drug Discovery Market Size by Application
    • 7.3.1 Europe Computational Drug Discovery Market Size by Application (2018-2023)
    • 7.3.2 Europe Computational Drug Discovery Market Size by Application (2024-2029)
    • 7.3.3 Europe Computational Drug Discovery Market Share by Application (2018-2029)
  • 7.4 Europe Computational Drug Discovery Market Size by Country
    • 7.4.1 Europe Computational Drug Discovery Market Size by Country: 2018 VS 2022 VS 2029
    • 7.4.2 Europe Computational Drug Discovery Market Size by Country (2018-2023)
    • 7.4.3 Europe Computational Drug Discovery Market Size by Country (2024-2029)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 China

  • 8.1 China Computational Drug Discovery Market Size (2018-2029)
  • 8.2 China Computational Drug Discovery Market Size by Type
    • 8.2.1 China Computational Drug Discovery Market Size by Type (2018-2023)
    • 8.2.2 China Computational Drug Discovery Market Size by Type (2024-2029)
    • 8.2.3 China Computational Drug Discovery Market Share by Type (2018-2029)
  • 8.3 China Computational Drug Discovery Market Size by Application
    • 8.3.1 China Computational Drug Discovery Market Size by Application (2018-2023)
    • 8.3.2 China Computational Drug Discovery Market Size by Application (2024-2029)
    • 8.3.3 China Computational Drug Discovery Market Share by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Computational Drug Discovery Market Size (2018-2029)
  • 9.2 Asia Computational Drug Discovery Market Size by Type
    • 9.2.1 Asia Computational Drug Discovery Market Size by Type (2018-2023)
    • 9.2.2 Asia Computational Drug Discovery Market Size by Type (2024-2029)
    • 9.2.3 Asia Computational Drug Discovery Market Share by Type (2018-2029)
  • 9.3 Asia Computational Drug Discovery Market Size by Application
    • 9.3.1 Asia Computational Drug Discovery Market Size by Application (2018-2023)
    • 9.3.2 Asia Computational Drug Discovery Market Size by Application (2024-2029)
    • 9.3.3 Asia Computational Drug Discovery Market Share by Application (2018-2029)
  • 9.4 Asia Computational Drug Discovery Market Size by Region
    • 9.4.1 Asia Computational Drug Discovery Market Size by Region: 2018 VS 2022 VS 2029
    • 9.4.2 Asia Computational Drug Discovery Market Size by Region (2018-2023)
    • 9.4.3 Asia Computational Drug Discovery Market Size by Region (2024-2029)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 China Taiwan
    • 9.4.7 Southeast Asia
    • 9.4.8 India
    • 9.4.9 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Computational Drug Discovery Market Size (2018-2029)
  • 10.2 Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Type (2018-2023)
    • 10.2.2 Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Type (2024-2029)
    • 10.2.3 Middle East, Africa, and Latin America Computational Drug Discovery Market Share by Type (2018-2029)
  • 10.3 Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Application (2018-2023)
    • 10.3.2 Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Application (2024-2029)
    • 10.3.3 Middle East, Africa, and Latin America Computational Drug Discovery Market Share by Application (2018-2029)
  • 10.4 Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Country: 2018 VS 2022 VS 2029
    • 10.4.2 Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Country (2018-2023)
    • 10.4.3 Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Country (2024-2029)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Saudi Arabia
    • 10.4.8 Israel
    • 10.4.9 GCC Countries

11 Key Players Profiles

  • 11.1 AMRI
    • 11.1.1 AMRI Company Details
    • 11.1.2 AMRI Business Overview
    • 11.1.3 AMRI Computational Drug Discovery Introduction
    • 11.1.4 AMRI Revenue in Computational Drug Discovery Business (2018-2023)
    • 11.1.5 AMRI Recent Developments
  • 11.2 Charles River
    • 11.2.1 Charles River Company Details
    • 11.2.2 Charles River Business Overview
    • 11.2.3 Charles River Computational Drug Discovery Introduction
    • 11.2.4 Charles River Revenue in Computational Drug Discovery Business (2018-2023)
    • 11.2.5 Charles River Recent Developments
  • 11.3 Schrodinger
    • 11.3.1 Schrodinger Company Details
    • 11.3.2 Schrodinger Business Overview
    • 11.3.3 Schrodinger Computational Drug Discovery Introduction
    • 11.3.4 Schrodinger Revenue in Computational Drug Discovery Business (2018-2023)
    • 11.3.5 Schrodinger Recent Developments
  • 11.4 Evotec
    • 11.4.1 Evotec Company Details
    • 11.4.2 Evotec Business Overview
    • 11.4.3 Evotec Computational Drug Discovery Introduction
    • 11.4.4 Evotec Revenue in Computational Drug Discovery Business (2018-2023)
    • 11.4.5 Evotec Recent Developments
  • 11.5 Bayers
    • 11.5.1 Bayers Company Details
    • 11.5.2 Bayers Business Overview
    • 11.5.3 Bayers Computational Drug Discovery Introduction
    • 11.5.4 Bayers Revenue in Computational Drug Discovery Business (2018-2023)
    • 11.5.5 Bayers Recent Developments
  • 11.6 GVK Biosciences
    • 11.6.1 GVK Biosciences Company Details
    • 11.6.2 GVK Biosciences Business Overview
    • 11.6.3 GVK Biosciences Computational Drug Discovery Introduction
    • 11.6.4 GVK Biosciences Revenue in Computational Drug Discovery Business (2018-2023)
    • 11.6.5 GVK Biosciences Recent Developments
  • 11.7 AstraZeneca
    • 11.7.1 AstraZeneca Company Details
    • 11.7.2 AstraZeneca Business Overview
    • 11.7.3 AstraZeneca Computational Drug Discovery Introduction
    • 11.7.4 AstraZeneca Revenue in Computational Drug Discovery Business (2018-2023)
    • 11.7.5 AstraZeneca Recent Developments
  • 11.8 BioDuro
    • 11.8.1 BioDuro Company Details
    • 11.8.2 BioDuro Business Overview
    • 11.8.3 BioDuro Computational Drug Discovery Introduction
    • 11.8.4 BioDuro Revenue in Computational Drug Discovery Business (2018-2023)
    • 11.8.5 BioDuro Recent Developments
  • 11.9 BOC Sciences
    • 11.9.1 BOC Sciences Company Details
    • 11.9.2 BOC Sciences Business Overview
    • 11.9.3 BOC Sciences Computational Drug Discovery Introduction
    • 11.9.4 BOC Sciences Revenue in Computational Drug Discovery Business (2018-2023)
    • 11.9.5 BOC Sciences Recent Developments
  • 11.10 Aris Pharmaceuticals
    • 11.10.1 Aris Pharmaceuticals Company Details
    • 11.10.2 Aris Pharmaceuticals Business Overview
    • 11.10.3 Aris Pharmaceuticals Computational Drug Discovery Introduction
    • 11.10.4 Aris Pharmaceuticals Revenue in Computational Drug Discovery Business (2018-2023)
    • 11.10.5 Aris Pharmaceuticals Recent Developments
  • 11.11 ChemDiv
    • 11.11.1 ChemDiv Company Details
    • 11.11.2 ChemDiv Business Overview
    • 11.11.3 ChemDiv Computational Drug Discovery Introduction
    • 11.11.4 ChemDiv Revenue in Computational Drug Discovery Business (2018-2023)
    • 11.11.5 ChemDiv Recent Developments
  • 11.12 RTI International
    • 11.12.1 RTI International Company Details
    • 11.12.2 RTI International Business Overview
    • 11.12.3 RTI International Computational Drug Discovery Introduction
    • 11.12.4 RTI International Revenue in Computational Drug Discovery Business (2018-2023)
    • 11.12.5 RTI International Recent Developments
  • 11.13 XRQTC
    • 11.13.1 XRQTC Company Details
    • 11.13.2 XRQTC Business Overview
    • 11.13.3 XRQTC Computational Drug Discovery Introduction
    • 11.13.4 XRQTC Revenue in Computational Drug Discovery Business (2018-2023)
    • 11.13.5 XRQTC Recent Developments
  • 11.14 Pharmaron
    • 11.14.1 Pharmaron Company Details
    • 11.14.2 Pharmaron Business Overview
    • 11.14.3 Pharmaron Computational Drug Discovery Introduction
    • 11.14.4 Pharmaron Revenue in Computational Drug Discovery Business (2018-2023)
    • 11.14.5 Pharmaron Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details

List of Tables

  • Table 1. Global Computational Drug Discovery Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
  • Table 2. Key Players of Structure-based Drug Design (SBDD)
  • Table 3. Key Players of Ligand-based Drug Design (LBDD)
  • Table 4. Key Players of Sequence-based Approaches
  • Table 5. Global Computational Drug Discovery Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
  • Table 6. Global Computational Drug Discovery Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 7. Global Computational Drug Discovery Market Size by Region (2018-2023) & (US$ Million)
  • Table 8. Global Computational Drug Discovery Market Share by Region (2018-2023)
  • Table 9. Global Computational Drug Discovery Forecasted Market Size by Region (2024-2029) & (US$ Million)
  • Table 10. Global Computational Drug Discovery Market Share by Region (2024-2029)
  • Table 11. Computational Drug Discovery Market Trends
  • Table 12. Computational Drug Discovery Market Drivers
  • Table 13. Computational Drug Discovery Market Challenges
  • Table 14. Computational Drug Discovery Market Restraints
  • Table 15. Global Computational Drug Discovery Revenue by Players (2018-2023) & (US$ Million)
  • Table 16. Global Computational Drug Discovery Revenue Share by Players (2018-2023)
  • Table 17. Global Top Computational Drug Discovery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computational Drug Discovery as of 2022)
  • Table 18. Global Computational Drug Discovery Industry Ranking 2021 VS 2022 VS 2023
  • Table 19. Global 5 Largest Players Market Share by Computational Drug Discovery Revenue (CR5 and HHI) & (2018-2023)
  • Table 20. Global Key Players of Computational Drug Discovery, Headquarters and Area Served
  • Table 21. Global Key Players of Computational Drug Discovery, Product and Application
  • Table 22. Global Key Players of Computational Drug Discovery, Product and Application
  • Table 23. Mergers & Acquisitions, Expansion Plans
  • Table 24. Global Computational Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
  • Table 25. Global Computational Drug Discovery Revenue Market Share by Type (2018-2023)
  • Table 26. Global Computational Drug Discovery Forecasted Market Size by Type (2024-2029) & (US$ Million)
  • Table 27. Global Computational Drug Discovery Revenue Market Share by Type (2024-2029)
  • Table 28. Global Computational Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
  • Table 29. Global Computational Drug Discovery Revenue Share by Application (2018-2023)
  • Table 30. Global Computational Drug Discovery Forecasted Market Size by Application (2024-2029) & (US$ Million)
  • Table 31. Global Computational Drug Discovery Revenue Share by Application (2024-2029)
  • Table 32. North America Computational Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
  • Table 33. North America Computational Drug Discovery Market Size by Type (2024-2029) & (US$ Million)
  • Table 34. North America Computational Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
  • Table 35. North America Computational Drug Discovery Market Size by Application (2024-2029) & (US$ Million)
  • Table 36. North America Computational Drug Discovery Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 37. North America Computational Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
  • Table 38. North America Computational Drug Discovery Market Size by Country (2024-2029) & (US$ Million)
  • Table 39. Europe Computational Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
  • Table 40. Europe Computational Drug Discovery Market Size by Type (2024-2029) & (US$ Million)
  • Table 41. Europe Computational Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
  • Table 42. Europe Computational Drug Discovery Market Size by Application (2024-2029) & (US$ Million)
  • Table 43. Europe Computational Drug Discovery Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 44. Europe Computational Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
  • Table 45. Europe Computational Drug Discovery Market Size by Country (2024-2029) & (US$ Million)
  • Table 46. China Computational Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
  • Table 47. China Computational Drug Discovery Market Size by Type (2024-2029) & (US$ Million)
  • Table 48. China Computational Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
  • Table 49. China Computational Drug Discovery Market Size by Application (2024-2029) & (US$ Million)
  • Table 50. Asia Computational Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
  • Table 51. Asia Computational Drug Discovery Market Size by Type (2024-2029) & (US$ Million)
  • Table 52. Asia Computational Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
  • Table 53. Asia Computational Drug Discovery Market Size by Application (2024-2029) & (US$ Million)
  • Table 54. Asia Computational Drug Discovery Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 55. Asia Computational Drug Discovery Market Size by Region (2018-2023) & (US$ Million)
  • Table 56. Asia Computational Drug Discovery Market Size by Region (2024-2029) & (US$ Million)
  • Table 57. Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
  • Table 58. Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Type (2024-2029) & (US$ Million)
  • Table 59. Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
  • Table 60. Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Application (2024-2029) & (US$ Million)
  • Table 61. Middle East, Africa, and Latin America Computational Drug Discovery Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 62. Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
  • Table 63. Middle East, Africa, and Latin America Computational Drug Discovery Market Size by Country (2024-2029) & (US$ Million)
  • Table 64. AMRI Company Details
  • Table 65. AMRI Business Overview
  • Table 66. AMRI Computational Drug Discovery Product
  • Table 67. AMRI Revenue in Computational Drug Discovery Business (2018-2023) & (US$ Million)
  • Table 68. AMRI Recent Developments
  • Table 69. Charles River Company Details
  • Table 70. Charles River Business Overview
  • Table 71. Charles River Computational Drug Discovery Product
  • Table 72. Charles River Revenue in Computational Drug Discovery Business (2018-2023) & (US$ Million)
  • Table 73. Charles River Recent Developments
  • Table 74. Schrodinger Company Details
  • Table 75. Schrodinger Business Overview
  • Table 76. Schrodinger Computational Drug Discovery Product
  • Table 77. Schrodinger Revenue in Computational Drug Discovery Business (2018-2023) & (US$ Million)
  • Table 78. Schrodinger Recent Developments
  • Table 79. Evotec Company Details
  • Table 80. Evotec Business Overview
  • Table 81. Evotec Computational Drug Discovery Product
  • Table 82. Evotec Revenue in Computational Drug Discovery Business (2018-2023) & (US$ Million)
  • Table 83. Evotec Recent Developments
  • Table 84. Bayers Company Details
  • Table 85. Bayers Business Overview
  • Table 86. Bayers Computational Drug Discovery Product
  • Table 87. Bayers Revenue in Computational Drug Discovery Business (2018-2023) & (US$ Million)
  • Table 88. Bayers Recent Developments
  • Table 89. GVK Biosciences Company Details
  • Table 90. GVK Biosciences Business Overview
  • Table 91. GVK Biosciences Computational Drug Discovery Product
  • Table 92. GVK Biosciences Revenue in Computational Drug Discovery Business (2018-2023) & (US$ Million)
  • Table 93. GVK Biosciences Recent Developments
  • Table 94. AstraZeneca Company Details
  • Table 95. AstraZeneca Business Overview
  • Table 96. AstraZeneca Computational Drug Discovery Product
  • Table 97. AstraZeneca Revenue in Computational Drug Discovery Business (2018-2023) & (US$ Million)
  • Table 98. AstraZeneca Recent Developments
  • Table 99. BioDuro Company Details
  • Table 100. BioDuro Business Overview
  • Table 101. BioDuro Computational Drug Discovery Product
  • Table 102. BioDuro Revenue in Computational Drug Discovery Business (2018-2023) & (US$ Million)
  • Table 103. BioDuro Recent Developments
  • Table 104. BOC Sciences Company Details
  • Table 105. BOC Sciences Business Overview
  • Table 106. BOC Sciences Computational Drug Discovery Product
  • Table 107. BOC Sciences Revenue in Computational Drug Discovery Business (2018-2023) & (US$ Million)
  • Table 108. BOC Sciences Recent Developments
  • Table 109. Aris Pharmaceuticals Company Details
  • Table 110. Aris Pharmaceuticals Business Overview
  • Table 111. Aris Pharmaceuticals Computational Drug Discovery Product
  • Table 112. Aris Pharmaceuticals Revenue in Computational Drug Discovery Business (2018-2023) & (US$ Million)
  • Table 113. Aris Pharmaceuticals Recent Developments
  • Table 114. ChemDiv Company Details
  • Table 115. ChemDiv Business Overview
  • Table 116. ChemDiv Computational Drug Discovery Product
  • Table 117. ChemDiv Revenue in Computational Drug Discovery Business (2018-2023) & (US$ Million)
  • Table 118. ChemDiv Recent Developments
  • Table 119. RTI International Company Details
  • Table 120. RTI International Business Overview
  • Table 121. RTI International Computational Drug Discovery Product
  • Table 122. RTI International Revenue in Computational Drug Discovery Business (2018-2023) & (US$ Million)
  • Table 123. RTI International Recent Developments
  • Table 124. XRQTC Company Details
  • Table 125. XRQTC Business Overview
  • Table 126. XRQTC Computational Drug Discovery Product
  • Table 127. XRQTC Revenue in Computational Drug Discovery Business (2018-2023) & (US$ Million)
  • Table 128. XRQTC Recent Developments
  • Table 129. Pharmaron Company Details
  • Table 130. Pharmaron Business Overview
  • Table 131. Pharmaron Computational Drug Discovery Product
  • Table 132. Pharmaron Revenue in Computational Drug Discovery Business (2018-2023) & (US$ Million)
  • Table 133. Pharmaron Recent Developments
  • Table 134. Research Programs/Design for This Report
  • Table 135. Key Data Information from Secondary Sources
  • Table 136. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Computational Drug Discovery Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 2. Global Computational Drug Discovery Market Share by Type: 2022 VS 2029
  • Figure 3. Structure-based Drug Design (SBDD) Features
  • Figure 4. Ligand-based Drug Design (LBDD) Features
  • Figure 5. Sequence-based Approaches Features
  • Figure 6. Global Computational Drug Discovery Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 7. Global Computational Drug Discovery Market Share by Application: 2022 VS 2029
  • Figure 8. Oncological Disorders Case Studies
  • Figure 9. Neurological Disorders Case Studies
  • Figure 10. Immunological Disorders Case Studies
  • Figure 11. Infectious Diseases Case Studies
  • Figure 12. Others Case Studies
  • Figure 13. Computational Drug Discovery Report Years Considered
  • Figure 14. Global Computational Drug Discovery Market Size (US$ Million), Year-over-Year: 2018-2029
  • Figure 15. Global Computational Drug Discovery Market Size, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 16. Global Computational Drug Discovery Market Share by Region: 2022 VS 2029
  • Figure 17. Global Computational Drug Discovery Market Share by Players in 2022
  • Figure 18. Global Top Computational Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computational Drug Discovery as of 2022)
  • Figure 19. The Top 10 and 5 Players Market Share by Computational Drug Discovery Revenue in 2022
  • Figure 20. North America Computational Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 21. North America Computational Drug Discovery Market Share by Type (2018-2029)
  • Figure 22. North America Computational Drug Discovery Market Share by Application (2018-2029)
  • Figure 23. North America Computational Drug Discovery Market Share by Country (2018-2029)
  • Figure 24. United States Computational Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 25. Canada Computational Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 26. Europe Computational Drug Discovery Market Size YoY (2018-2029) & (US$ Million)
  • Figure 27. Europe Computational Drug Discovery Market Share by Type (2018-2029)
  • Figure 28. Europe Computational Drug Discovery Market Share by Application (2018-2029)
  • Figure 29. Europe Computational Drug Discovery Market Share by Country (2018-2029)
  • Figure 30. Germany Computational Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 31. France Computational Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 32. U.K. Computational Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 33. Italy Computational Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 34. Russia Computational Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 35. Nordic Countries Computational Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 36. China Computational Drug Discovery Market Size YoY (2018-2029) & (US$ Million)
  • Figure 37. China Computational Drug Discovery Market Share by Type (2018-2029)
  • Figure 38. China Computational Drug Discovery Market Share by Application (2018-2029)
  • Figure 39. Asia Computational Drug Discovery Market Size YoY (2018-2029) & (US$ Million)
  • Figure 40. Asia Computational Drug Discovery Market Share by Type (2018-2029)
  • Figure 41. Asia Computational Drug Discovery Market Share by Application (2018-2029)
  • Figure 42. Asia Computational Drug Discovery Market Share by Region (2018-2029)
  • Figure 43. Japan Computational Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 44. South Korea Computational Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 45. China Taiwan Computational Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 46. Southeast Asia Computational Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 47. India Computational Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 48. Australia Computational Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 49. Middle East, Africa, and Latin America Computational Drug Discovery Market Size YoY (2018-2029) & (US$ Million)
  • Figure 50. Middle East, Africa, and Latin America Computational Drug Discovery Market Share by Type (2018-2029)
  • Figure 51. Middle East, Africa, and Latin America Computational Drug Discovery Market Share by Application (2018-2029)
  • Figure 52. Middle East, Africa, and Latin America Computational Drug Discovery Market Share by Country (2018-2029)
  • Figure 53. Brazil Computational Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 54. Mexico Computational Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 55. Turkey Computational Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 56. Saudi Arabia Computational Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 57. Israel Computational Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 58. GCC Countries Computational Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 59. AMRI Revenue Growth Rate in Computational Drug Discovery Business (2018-2023)
  • Figure 60. Charles River Revenue Growth Rate in Computational Drug Discovery Business (2018-2023)
  • Figure 61. Schrodinger Revenue Growth Rate in Computational Drug Discovery Business (2018-2023)
  • Figure 62. Evotec Revenue Growth Rate in Computational Drug Discovery Business (2018-2023)
  • Figure 63. Bayers Revenue Growth Rate in Computational Drug Discovery Business (2018-2023)
  • Figure 64. GVK Biosciences Revenue Growth Rate in Computational Drug Discovery Business (2018-2023)
  • Figure 65. AstraZeneca Revenue Growth Rate in Computational Drug Discovery Business (2018-2023)
  • Figure 66. BioDuro Revenue Growth Rate in Computational Drug Discovery Business (2018-2023)
  • Figure 67. BOC Sciences Revenue Growth Rate in Computational Drug Discovery Business (2018-2023)
  • Figure 68. Aris Pharmaceuticals Revenue Growth Rate in Computational Drug Discovery Business (2018-2023)
  • Figure 69. ChemDiv Revenue Growth Rate in Computational Drug Discovery Business (2018-2023)
  • Figure 70. RTI International Revenue Growth Rate in Computational Drug Discovery Business (2018-2023)
  • Figure 71. XRQTC Revenue Growth Rate in Computational Drug Discovery Business (2018-2023)
  • Figure 72. Pharmaron Revenue Growth Rate in Computational Drug Discovery Business (2018-2023)
  • Figure 73. Bottom-up and Top-down Approaches for This Report
  • Figure 74. Data Triangulation
  • Figure 75. Key Executives Interviewed
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!